Ivacaftor restores delayed mucociliary transport caused by Pseudomonas aeruginosa–induced acquired cystic fibrosis transmembrane conductance regulator dysfunction in rabbit nasal epithelia

Background Abnormal chloride (Cl–) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis. As an experimental epithelium, rabbit tissue provides an excellent representation of human sinus disease, and the rabbit sinusitis model is...

Full description

Saved in:
Bibliographic Details
Published inInternational forum of allergy & rhinology Vol. 12; no. 5; pp. 690 - 698
Main Authors Cho, Do‐Yeon, Zhang, Shaoyan, Skinner, Daniel F., Lim, Dong Jin, Banks, Catherine, Grayson, Jessica W., Tearney, Guillermo J., Rowe, Steven M., Woodworth, Bradford A.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Abnormal chloride (Cl–) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis. As an experimental epithelium, rabbit tissue provides an excellent representation of human sinus disease, and the rabbit sinusitis model is both established and well suited for therapeutic interventions in vivo. Our objective in this study was to evaluate whether ivacaftor reverses the consequences of Pseudomonas aeruginosa–induced acquired cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. Methods Rabbit nasal cavities were assessed for responsiveness to ivacaftor in vivo (by nasal potential difference [NPD] assay). Rabbit nasal epithelial (RNE) cultures were incubated with an ultrafiltrate of P aeruginosa (PAO1 strain) for 4 hours and tested for acquired CFTR dysfunction. Markers of mucociliary function, including airway surface liquid depth (ASL), periciliary liquid depth (PCL), ciliary beat frequency (CBF), and mucociliary transport (MCT), were measured by micro‐optical coherence tomography (μOCT) after PAO1 and/or ivacaftor incubation. Results Ivacaftor resulted in a significant mean NPD polarization of 21.8 ± 2.1 mV, which was significantly greater than that seen in the low Cl− control (12.9 ± 1.3; p = 0.01). PAO1 exposure induced a state of acquired CFTR dysfunction in rabbit nasal epithelium as measured by forskolin‐stimulated short‐circuit current (ISC) (control, 37.0 ± 1.1 μA/cm2; PAO1, 24.4 ± 1.1 μA/cm2; p < 0.001). RNE cultures exposed to PAO1 had inhibited mucociliary function, whereas coincubation with ivacaftor restored mucociliary clearance, as measured by μOCT. Conclusion In rabbit nasal epithelium, ivacaftor robustly stimulates CFTR‐mediated Cl− secretion and normalizes ASL and CBF in PAO1‐induced acquired CFTR dysfunction. Preclinical testing of CFTR potentiators as therapy for P aeruginosa rabbit sinusitis is planned.
AbstractList BackgroundAbnormal chloride (Cl–) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis. As an experimental epithelium, rabbit tissue provides an excellent representation of human sinus disease, and the rabbit sinusitis model is both established and well suited for therapeutic interventions in vivo. Our objective in this study was to evaluate whether ivacaftor reverses the consequences of Pseudomonas aeruginosa–induced acquired cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction.MethodsRabbit nasal cavities were assessed for responsiveness to ivacaftor in vivo (by nasal potential difference [NPD] assay). Rabbit nasal epithelial (RNE) cultures were incubated with an ultrafiltrate of P aeruginosa (PAO1 strain) for 4 hours and tested for acquired CFTR dysfunction. Markers of mucociliary function, including airway surface liquid depth (ASL), periciliary liquid depth (PCL), ciliary beat frequency (CBF), and mucociliary transport (MCT), were measured by micro‐optical coherence tomography (μOCT) after PAO1 and/or ivacaftor incubation.ResultsIvacaftor resulted in a significant mean NPD polarization of 21.8 ± 2.1 mV, which was significantly greater than that seen in the low Cl− control (12.9 ± 1.3; p = 0.01). PAO1 exposure induced a state of acquired CFTR dysfunction in rabbit nasal epithelium as measured by forskolin‐stimulated short‐circuit current (ISC) (control, 37.0 ± 1.1 μA/cm2; PAO1, 24.4 ± 1.1 μA/cm2; p < 0.001). RNE cultures exposed to PAO1 had inhibited mucociliary function, whereas coincubation with ivacaftor restored mucociliary clearance, as measured by μOCT.ConclusionIn rabbit nasal epithelium, ivacaftor robustly stimulates CFTR‐mediated Cl− secretion and normalizes ASL and CBF in PAO1‐induced acquired CFTR dysfunction. Preclinical testing of CFTR potentiators as therapy for P aeruginosa rabbit sinusitis is planned.
Background Abnormal chloride (Cl – ) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis. As an experimental epithelium, rabbit tissue provides an excellent representation of human sinus disease, and the rabbit sinusitis model is both established and well suited for therapeutic interventions in vivo. Our objective in this study was to evaluate whether ivacaftor reverses the consequences of Pseudomonas aeruginosa– induced acquired cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. Methods Rabbit nasal cavities were assessed for responsiveness to ivacaftor in vivo (by nasal potential difference [NPD] assay). Rabbit nasal epithelial (RNE) cultures were incubated with an ultrafiltrate of P aeruginosa (PAO1 strain) for 4 hours and tested for acquired CFTR dysfunction. Markers of mucociliary function, including airway surface liquid depth (ASL), periciliary liquid depth (PCL), ciliary beat frequency (CBF), and mucociliary transport (MCT), were measured by micro‐optical coherence tomography (μOCT) after PAO1 and/or ivacaftor incubation. Results Ivacaftor resulted in a significant mean NPD polarization of 21.8 ± 2.1 mV, which was significantly greater than that seen in the low Cl − control (12.9 ± 1.3; p  = 0.01). PAO1 exposure induced a state of acquired CFTR dysfunction in rabbit nasal epithelium as measured by forskolin‐stimulated short‐circuit current (I SC ) (control, 37.0 ± 1.1 μA/cm 2 ; PAO1, 24.4 ± 1.1 μA/cm 2 ;  p  < 0.001). RNE cultures exposed to PAO1 had inhibited mucociliary function, whereas coincubation with ivacaftor restored mucociliary clearance, as measured by μOCT. Conclusion In rabbit nasal epithelium, ivacaftor robustly stimulates CFTR‐mediated Cl − secretion and normalizes ASL and CBF in PAO1‐induced acquired CFTR dysfunction. Preclinical testing of CFTR potentiators as therapy for P aeruginosa rabbit sinusitis is planned.
Abnormal chloride (Cl ) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis. As an experimental epithelium, rabbit tissue provides an excellent representation of human sinus disease, and the rabbit sinusitis model is both established and well suited for therapeutic interventions in vivo. Our objective in this study was to evaluate whether ivacaftor reverses the consequences of Pseudomonas aeruginosa-induced acquired cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. Rabbit nasal cavities were assessed for responsiveness to ivacaftor in vivo (by nasal potential difference [NPD] assay). Rabbit nasal epithelial (RNE) cultures were incubated with an ultrafiltrate of P aeruginosa (PAO1 strain) for 4 hours and tested for acquired CFTR dysfunction. Markers of mucociliary function, including airway surface liquid depth (ASL), periciliary liquid depth (PCL), ciliary beat frequency (CBF), and mucociliary transport (MCT), were measured by micro-optical coherence tomography (μOCT) after PAO1 and/or ivacaftor incubation. Ivacaftor resulted in a significant mean NPD polarization of 21.8 ± 2.1 mV, which was significantly greater than that seen in the low Cl control (12.9 ± 1.3; p = 0.01). PAO1 exposure induced a state of acquired CFTR dysfunction in rabbit nasal epithelium as measured by forskolin-stimulated short-circuit current (I ) (control, 37.0 ± 1.1 μA/cm ; PAO1, 24.4 ± 1.1 μA/cm ; p < 0.001). RNE cultures exposed to PAO1 had inhibited mucociliary function, whereas coincubation with ivacaftor restored mucociliary clearance, as measured by μOCT. In rabbit nasal epithelium, ivacaftor robustly stimulates CFTR-mediated Cl secretion and normalizes ASL and CBF in PAO1-induced acquired CFTR dysfunction. Preclinical testing of CFTR potentiators as therapy for P aeruginosa rabbit sinusitis is planned.
Background Abnormal chloride (Cl–) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis. As an experimental epithelium, rabbit tissue provides an excellent representation of human sinus disease, and the rabbit sinusitis model is both established and well suited for therapeutic interventions in vivo. Our objective in this study was to evaluate whether ivacaftor reverses the consequences of Pseudomonas aeruginosa–induced acquired cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. Methods Rabbit nasal cavities were assessed for responsiveness to ivacaftor in vivo (by nasal potential difference [NPD] assay). Rabbit nasal epithelial (RNE) cultures were incubated with an ultrafiltrate of P aeruginosa (PAO1 strain) for 4 hours and tested for acquired CFTR dysfunction. Markers of mucociliary function, including airway surface liquid depth (ASL), periciliary liquid depth (PCL), ciliary beat frequency (CBF), and mucociliary transport (MCT), were measured by micro‐optical coherence tomography (μOCT) after PAO1 and/or ivacaftor incubation. Results Ivacaftor resulted in a significant mean NPD polarization of 21.8 ± 2.1 mV, which was significantly greater than that seen in the low Cl− control (12.9 ± 1.3; p = 0.01). PAO1 exposure induced a state of acquired CFTR dysfunction in rabbit nasal epithelium as measured by forskolin‐stimulated short‐circuit current (ISC) (control, 37.0 ± 1.1 μA/cm2; PAO1, 24.4 ± 1.1 μA/cm2; p < 0.001). RNE cultures exposed to PAO1 had inhibited mucociliary function, whereas coincubation with ivacaftor restored mucociliary clearance, as measured by μOCT. Conclusion In rabbit nasal epithelium, ivacaftor robustly stimulates CFTR‐mediated Cl− secretion and normalizes ASL and CBF in PAO1‐induced acquired CFTR dysfunction. Preclinical testing of CFTR potentiators as therapy for P aeruginosa rabbit sinusitis is planned.
BACKGROUNDAbnormal chloride (Cl- ) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis. As an experimental epithelium, rabbit tissue provides an excellent representation of human sinus disease, and the rabbit sinusitis model is both established and well suited for therapeutic interventions in vivo. Our objective in this study was to evaluate whether ivacaftor reverses the consequences of Pseudomonas aeruginosa-induced acquired cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. METHODSRabbit nasal cavities were assessed for responsiveness to ivacaftor in vivo (by nasal potential difference [NPD] assay). Rabbit nasal epithelial (RNE) cultures were incubated with an ultrafiltrate of P aeruginosa (PAO1 strain) for 4 hours and tested for acquired CFTR dysfunction. Markers of mucociliary function, including airway surface liquid depth (ASL), periciliary liquid depth (PCL), ciliary beat frequency (CBF), and mucociliary transport (MCT), were measured by micro-optical coherence tomography (μOCT) after PAO1 and/or ivacaftor incubation. RESULTSIvacaftor resulted in a significant mean NPD polarization of 21.8 ± 2.1 mV, which was significantly greater than that seen in the low Cl- control (12.9 ± 1.3; p = 0.01). PAO1 exposure induced a state of acquired CFTR dysfunction in rabbit nasal epithelium as measured by forskolin-stimulated short-circuit current (ISC ) (control, 37.0 ± 1.1 μA/cm2 ; PAO1, 24.4 ± 1.1 μA/cm2 ; p < 0.001). RNE cultures exposed to PAO1 had inhibited mucociliary function, whereas coincubation with ivacaftor restored mucociliary clearance, as measured by μOCT. CONCLUSIONIn rabbit nasal epithelium, ivacaftor robustly stimulates CFTR-mediated Cl- secretion and normalizes ASL and CBF in PAO1-induced acquired CFTR dysfunction. Preclinical testing of CFTR potentiators as therapy for P aeruginosa rabbit sinusitis is planned.
Author Lim, Dong Jin
Banks, Catherine
Cho, Do‐Yeon
Zhang, Shaoyan
Grayson, Jessica W.
Tearney, Guillermo J.
Woodworth, Bradford A.
Skinner, Daniel F.
Rowe, Steven M.
Author_xml – sequence: 1
  givenname: Do‐Yeon
  orcidid: 0000-0002-5173-8959
  surname: Cho
  fullname: Cho, Do‐Yeon
  organization: Veterans Affairs
– sequence: 2
  givenname: Shaoyan
  surname: Zhang
  fullname: Zhang, Shaoyan
  organization: University of Alabama at Birmingham
– sequence: 3
  givenname: Daniel F.
  surname: Skinner
  fullname: Skinner, Daniel F.
  organization: University of Alabama at Birmingham
– sequence: 4
  givenname: Dong Jin
  surname: Lim
  fullname: Lim, Dong Jin
  organization: University of Alabama at Birmingham
– sequence: 5
  givenname: Catherine
  orcidid: 0000-0002-3966-6964
  surname: Banks
  fullname: Banks, Catherine
  organization: University of Alabama at Birmingham
– sequence: 6
  givenname: Jessica W.
  orcidid: 0000-0002-2131-8005
  surname: Grayson
  fullname: Grayson, Jessica W.
  organization: University of Alabama at Birmingham
– sequence: 7
  givenname: Guillermo J.
  surname: Tearney
  fullname: Tearney, Guillermo J.
  organization: Harvard Medical School
– sequence: 8
  givenname: Steven M.
  surname: Rowe
  fullname: Rowe, Steven M.
  organization: University of Alabama at Birmingham
– sequence: 9
  givenname: Bradford A.
  orcidid: 0000-0003-3292-9167
  surname: Woodworth
  fullname: Woodworth, Bradford A.
  email: bwoodworth@uabmc.edu
  organization: University of Alabama at Birmingham
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34704673$$D View this record in MEDLINE/PubMed
BookMark eNp1kcFqFTEUhoNUbK1d-AIScKOL2yaZSWZmWYrVwgVFdD2cJGdqykxym0wqs_Md-j4-jE9irlO7EMzmHDgff37-_zk58MEjIS85O-WMiTMY46kQHWuekCPBarFRXVsfPO6NOiQnKd2w8iSXkjfPyGFVN6xWTXVEfl7dgYFhDpFGTGVgohZHWNDSKZtg3OggLnSO4NMuxJkayKkc9UI_Jcw2TMFDooAxXzsfEvz6ce-8zaYwYG6zi2UxS5qdoYPTMSSXVrUJJ10mUhP2_AzeYDFxnUfY27FLGrI3swueOk8jaO1mWv6CkeLOzd-wOHtBng4wJjx5mMfk6-W7LxcfNtuP768uzrcbU7Vts0GljbAS5WCV4a0QXGsFSqtKtbpFbDqJvALTwqC7zg687gZhdaOhNlJYqI7Jm1V3F8NtLkH1k0sGx7H4Dzn1QrZNCViJuqCv_0FvQo6-uOuFkrVkvGNVod6ulCmJpIhDv4tuKkn3nPX7XvvSa_-n18K-elDMekL7SP5tsQBnK_Ddjbj8X6k_335eJX8DwjC2Ow
CitedBy_id crossref_primary_10_1002_alr_23301
crossref_primary_10_1016_j_otc_2022_09_009
crossref_primary_10_1002_alr_23309
crossref_primary_10_1177_01455613231214622
crossref_primary_10_1186_s12931_024_02889_w
crossref_primary_10_1002_lary_31431
crossref_primary_10_1016_j_jcf_2023_09_002
Cites_doi 10.1016/j.wjorl.2018.09.001
10.1002/lary.25335
10.1016/j.otohns.2010.05.021
10.3389/fcimb.2017.00540
10.1073/pnas.0904709106
10.2500/ajra.2010.24.3379
10.1002/alr.22514
10.1002/alr.22251
10.2500/ajr.2007.21.3068
10.1002/alr.22202
10.1002/alr.21335
10.1371/journal.ppat.1004946
10.3389/fcimb.2020.00412
10.1126/scitranslmed.aav3505
10.1002/alr.22290
10.1002/lio2.423
10.1177/1945892418815615
10.1164/rccm.202002-0369OC
10.1371/journal.pone.0081589
10.1038/nrdp.2015.10
10.1016/j.redox.2021.101998
10.1016/j.ijporl.2019.05.034
10.1002/alr.21892
10.2500/ajra.2011.25.3643
10.1002/alr.22088
10.2500/ajr.2008.22.3125
10.1002/alr.22081
10.1371/journal.pone.0054473
10.1097/MCP.0000000000000107
10.1007/s40136-017-0139-3
10.1165/rcmb.2010-0133OC
10.1056/NEJMoa0909825
10.1002/alr.22285
10.1002/lary.23278
10.1002/lary.20930
10.1096/fj.14-268755
10.1002/alr.21975
10.1002/alr.22065
10.1002/lary.21921
10.2500/ajra.2009.23.3285
10.1371/journal.pone.0072398
10.1002/lary.20871
10.1007/s11882-020-00916-6
10.1002/lary.21798
ContentType Journal Article
Copyright 2021 ARS‐AAOA, LLC
2021 ARS-AAOA, LLC.
2022 ARS‐AAOA, LLC
Copyright_xml – notice: 2021 ARS‐AAOA, LLC
– notice: 2021 ARS-AAOA, LLC.
– notice: 2022 ARS‐AAOA, LLC
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7X8
DOI 10.1002/alr.22907
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
CrossRef
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2042-6984
EndPage 698
ExternalDocumentID 10_1002_alr_22907
34704673
ALR22907
Genre article
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R35 HL135816
– fundername: NIAID NIH HHS
  grantid: K08 AI146220
– fundername: NIDDK NIH HHS
  grantid: P30 DK072482
– fundername: NHLBI NIH HHS
  grantid: K08 HL107142
– fundername: NHLBI NIH HHS
  grantid: R01 HL133006
– fundername: NIAID NIH HHS
  grantid: R21 AI168894
GroupedDBID ---
05W
0R~
1OC
31~
33P
4.4
50Y
52T
52V
53G
7PT
8-0
8-1
A00
AAESR
AAHHS
AANLZ
AASGY
AAXRX
AAZKR
ABCUV
ABDBF
ABJNI
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AENEX
AEQDE
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
ASPBG
AVWKF
AZFZN
AZVAB
BDRZF
BFHJK
BMXJE
BRXPI
D-A
DCZOG
DRFUL
DRMAN
DRSTM
EBD
EBS
EJD
FEDTE
FUBAC
G-S
GODZA
HGLYW
HVGLF
HZ~
KBYEO
LATKE
LEEKS
LITHE
LOXES
LP6
LP7
LUTES
LYRES
MEWTI
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY.
MY~
O9-
OVD
P2W
P4E
PQQKQ
ROL
RX1
SUPJJ
TEORI
WBKPD
WOHZO
WXSBR
WYJ
ZZTAW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7X8
ID FETCH-LOGICAL-c3887-e6bc2d5e5fd6c18221bb6a6b6368b8ee795e13ac8afb99df149f2db7ba4c52da3
ISSN 2042-6976
IngestDate Wed Jul 24 13:00:03 EDT 2024
Fri Sep 13 08:22:14 EDT 2024
Fri Aug 23 01:33:27 EDT 2024
Tue Aug 27 13:49:29 EDT 2024
Sat Aug 24 01:03:19 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords micro-optical coherence tomography
cystic fibrosis
chronic rhinosinusitis
sinusitis
mucociliary clearance
ivacaftor
CFTR
chronic sinusitis
mucociliary transport
Language English
License 2021 ARS-AAOA, LLC.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3887-e6bc2d5e5fd6c18221bb6a6b6368b8ee795e13ac8afb99df149f2db7ba4c52da3
Notes Funding information
National Institutes of Health (NIH)/National Institutes of Allergy and Infectious Disease (grant K08AI146220‐02 to D.Y.C.); NIH/National Institute of Diabetes and Digestive and Kidney Diseases (grant 5P30DK072482‐03 to S.M.R.); NIH/NHLBI (grants R01 HL133006‐05 and K08HL107142‐05 to B.A.W.).
Potential conflict of interest: B.A.W: consultant for Cook Medical and Smith and Nephew.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-3292-9167
0000-0002-3966-6964
0000-0002-2131-8005
0000-0002-5173-8959
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038953
PMID 34704673
PQID 2654501903
PQPubID 996378
PageCount 9
ParticipantIDs proquest_miscellaneous_2587000624
proquest_journals_2654501903
crossref_primary_10_1002_alr_22907
pubmed_primary_34704673
wiley_primary_10_1002_alr_22907_ALR22907
PublicationCentury 2000
PublicationDate May 2022
2022-05-00
20220501
PublicationDateYYYYMMDD 2022-05-01
PublicationDate_xml – month: 05
  year: 2022
  text: May 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle International forum of allergy & rhinology
PublicationTitleAlternate Int Forum Allergy Rhinol
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2017; 5
2009; 23
2015; 1
2017; 7
2019; 9
2021; 43
2012; 122
2020; 20
2019; 33
2019; 11
2019; 10
2015; 125
2015; 11
2010; 363
2010; 143
2019; 124
2010; 120
2020; 202
2020; 10
2013; 8
2016; 79
2014; 20
2018; 8
2020; 5
2014; 4
2018; 4
2015; 29
2010; 24
2013; 139
2011; 45
2008; 22
2011; 25
2007; 21
2011; 121
2009; 106
e_1_2_5_27_1
e_1_2_5_28_1
e_1_2_5_25_1
e_1_2_5_48_1
e_1_2_5_26_1
e_1_2_5_47_1
e_1_2_5_23_1
e_1_2_5_46_1
e_1_2_5_24_1
e_1_2_5_45_1
e_1_2_5_21_1
e_1_2_5_44_1
e_1_2_5_22_1
Conger BT (e_1_2_5_40_1) 2013; 139
e_1_2_5_43_1
Karanth TK (e_1_2_5_3_1) 2019; 10
e_1_2_5_29_1
e_1_2_5_42_1
e_1_2_5_20_1
e_1_2_5_41_1
e_1_2_5_15_1
e_1_2_5_38_1
e_1_2_5_14_1
e_1_2_5_39_1
e_1_2_5_17_1
e_1_2_5_36_1
e_1_2_5_9_1
e_1_2_5_16_1
e_1_2_5_37_1
e_1_2_5_8_1
e_1_2_5_11_1
e_1_2_5_34_1
e_1_2_5_7_1
Cho DY (e_1_2_5_10_1) 2016; 79
e_1_2_5_35_1
e_1_2_5_6_1
e_1_2_5_13_1
e_1_2_5_32_1
e_1_2_5_5_1
e_1_2_5_12_1
e_1_2_5_33_1
e_1_2_5_4_1
e_1_2_5_2_1
e_1_2_5_19_1
e_1_2_5_18_1
e_1_2_5_30_1
e_1_2_5_31_1
References_xml – volume: 20
  year: 2020
  article-title: Phenotypes in chronic rhinosinusitis
  publication-title: Curr Allergy Asthma Rep
– volume: 9
  start-page: 486
  year: 2019
  end-page: 492
  article-title: In‐vitro evaluation of a ciprofloxacin‐ and ivacaftor‐coated sinus stent against biofilms
  publication-title: Int Forum Allergy Rhinol
– volume: 8
  start-page: 577
  year: 2018
  end-page: 583
  article-title: L‐Methionine anti‐biofilm activity against is enhanced by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor
  publication-title: Int Forum Allergy Rhinol
– volume: 139
  start-page: 822
  year: 2013
  end-page: 827
  article-title: Comparison of cystic fibrosis transmembrane conductance regulator (CFTR) and ciliary beat frequency activation by the CFTR modulators genistein, VRT‐532, and UCCF‐152 in primary sinonasal epithelial cultures
  publication-title: JAMA Otolaryngol
– volume: 10
  year: 2019
  article-title: Medical interventions for chronic rhinosinusitis in cystic fibrosis
  publication-title: Cochrane Database Syst Rev
– volume: 29
  start-page: 2712
  year: 2015
  end-page: 2725
  article-title: Influenza virus M2 targets cystic fibrosis transmembrane conductance regulator for lysosomal degradation during viral infection
  publication-title: FASEB J
– volume: 8
  year: 2013
  article-title: Method for quantitative study of airway functional microanatomy using micro‐optical coherence tomography
  publication-title: PLoS One
– volume: 33
  start-page: 129
  year: 2019
  end-page: 136
  article-title: Ivacaftor, a cystic fibrosis transmembrane conductance regulator potentiator, enhances ciprofloxacin activity against pseudomonas aeruginosa
  publication-title: Am J Rhinol Allergy
– volume: 9
  start-page: 292
  year: 2019
  end-page: 297
  article-title: Ivacaftor improves rhinologic, psychologic, and sleep‐related quality of life in G551D cystic fibrosis patients
  publication-title: Int Forum Allergy Rhinol
– volume: 106
  start-page: 18825
  year: 2009
  end-page: 18830
  article-title: Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX‐770
  publication-title: Proc Natl Acad Sci USA
– volume: 20
  start-page: 623
  year: 2014
  end-page: 631
  article-title: Management of the upper airway in cystic fibrosis
  publication-title: Curr Opin Pulmon Med
– volume: 125
  start-page: S1
  year: 2015
  end-page: S13
  article-title: Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia‐Induced model of acquired CFTR deficiency
  publication-title: Laryngoscope
– volume: 8
  year: 2013
  article-title: IP‐10 is a potential biomarker of cystic fibrosis acute pulmonary exacerbations
  publication-title: PLoS One
– volume: 21
  start-page: 533
  year: 2007
  end-page: 537
  article-title: Murine tracheal and nasal septal epithelium for air‐liquid interface cultures: a comparative study
  publication-title: Am J Rhinol
– volume: 124
  start-page: 139
  year: 2019
  end-page: 142
  article-title: Chronic rhino‐sinusitis treatment in children with cystic fibrosis: a cross‐sectional survey of pediatric pulmonologists and otolaryngologists
  publication-title: Int J Pediatr Otorhinolaryngol
– volume: 121
  start-page: 1929
  year: 2011
  end-page: 1934
  article-title: Transepithelial ion transport is suppressed in hypoxic sinonasal epithelium
  publication-title: Laryngoscope
– volume: 25
  start-page: 307
  year: 2011
  end-page: 312
  article-title: Quercetin increases cystic fibrosis transmembrane conductance regulator‐mediated chloride transport and ciliary beat frequency: therapeutic implications for chronic rhinosinusitis
  publication-title: Am J Rhinol Allergy
– volume: 4
  start-page: 565
  year: 2014
  end-page: 570
  article-title: Porcine nasal epithelial cultures for studies of cystic fibrosis sinusitis
  publication-title: Int Forum Allergy Rhinol
– volume: 45
  start-page: 525
  year: 2011
  end-page: 533
  article-title: Glandular gene expression of sinus mucosa in chronic rhinosinusitis with and without cystic fibrosis
  publication-title: Am J Respir Cell Mol Biol
– volume: 363
  start-page: 1991
  year: 2010
  end-page: 2003
  article-title: Effect of VX‐770 in persons with cystic fibrosis and the G551D‐CFTR mutation
  publication-title: N Engl J Med
– volume: 8
  start-page: 482
  year: 2018
  end-page: 489
  article-title: Preclinical therapeutic efficacy of the ciprofloxacin‐eluting sinus stent for sinusitis
  publication-title: Int Forum Allergy Rhinol
– volume: 7
  start-page: 920
  year: 2017
  end-page: 925
  article-title: Assessment of acquired mucociliary clearance defects using micro‐optical coherence tomography
  publication-title: Int Forum Allergy Rhinol
– volume: 5
  start-page: 24
  year: 2017
  end-page: 34
  article-title: Medical and surgical advancements in the management of cystic fibrosis chronic rhinosinusitis
  publication-title: Curr Otorhinolaryngol Rep
– volume: 1
  year: 2015
  article-title: Cystic fibrosis
  publication-title: Nat Rev Dis Primers
– volume: 202
  start-page: 1271
  year: 2020
  end-page: 1282
  article-title: Ivacaftor reverses airway mucus abnormalities in a rat model harboring a humanized G551D‐CFTR
  publication-title: Am J Respir Crit Care Med
– volume: 11
  year: 2019
  article-title: Intranasal micro‐optical coherence tomography imaging for cystic fibrosis studies
  publication-title: Sci Transl Med
– volume: 7
  start-page: 352
  year: 2017
  end-page: 358
  article-title: Tolerance and pharmacokinetics of a ciprofloxacin‐coated sinus stent in a preclinical model
  publication-title: Int Forum Allergy Rhinol
– volume: 120
  start-page: 1465
  year: 2010
  end-page: 1469
  article-title: Exposure to cigarette smoke condensate reduces calcium activated chloride channel transport in primary sinonasal epithelial cultures
  publication-title: Laryngoscope
– volume: 22
  start-page: 7
  year: 2008
  end-page: 12
  article-title: Transient receptor potential vanilloid type 4 channel expression in chronic rhinosinusitis
  publication-title: Am J Rhinol
– volume: 10
  start-page: 481
  year: 2020
  end-page: 488
  article-title: Controlled delivery of ciprofloxacin and ivacaftor via sinus stent in a preclinical model of sinusitis
  publication-title: Int Forum Allergy Rhinol
– volume: 24
  start-page: 6
  year: 2010
  end-page: 10
  article-title: Zinc increases ciliary beat frequency in a calcium‐dependent manner
  publication-title: Am J Rhinol Allergy
– volume: 5
  start-page: 598
  year: 2020
  end-page: 607
  article-title: Antibiotic eluting sinus stents
  publication-title: Laryngoscope Investig Otolaryngol
– volume: 23
  start-page: 149
  year: 2009
  end-page: 152
  article-title: Comparison of vectorial ion transport in primary murine airway and human sinonasal air‐liquid interface cultures, models for studies of cystic fibrosis, and other airway diseases
  publication-title: Am J Rhinol Allergy
– volume: 122
  start-page: 1193
  year: 2012
  end-page: 1197
  article-title: Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein
  publication-title: Laryngoscope
– volume: 10
  year: 2020
  article-title: Contribution of short chain fatty acids to the growth of in rhinosinusitis
  publication-title: Front Cell Infect Microbiol
– volume: 9
  start-page: 629
  year: 2019
  end-page: 637
  article-title: Herbal dry extract BNO 1011 improves clinical and mucociliary parameters in a rabbit model of chronic rhinosinusitis
  publication-title: Int Forum Allergy Rhinol
– volume: 8
  start-page: 509
  year: 2018
  end-page: 512
  article-title: Submucosal gland mucus strand velocity is decreased in chronic rhinosinusitis
  publication-title: Int Forum Allergy Rhinol
– volume: 79
  start-page: 78
  year: 2016
  end-page: 85
  article-title: Acquired cystic fibrosis transmembrane conductance regulator deficiency
  publication-title: Adv Otorhinolaryngol
– volume: 7
  start-page: 540
  year: 2017
  end-page: 577
  article-title: Sinus microanatomy and microbiota in a rabbit model of rhinosinusitis
  publication-title: Front Cell Infect Microbiol
– volume: 43
  year: 2021
  article-title: LPS decreases CFTR open probability and mucociliary transport through generation of reactive oxygen species
  publication-title: Redox Biol
– volume: 143
  start-page: 397
  year: 2010
  end-page: 404
  article-title: Hesperidin stimulates cystic fibrosis transmembrane conductance regulator‐mediated chloride secretion and ciliary beat frequency in sinonasal epithelium
  publication-title: Otolaryngol Head Neck Surg
– volume: 4
  start-page: 193
  year: 2018
  end-page: 199
  article-title: Acquired cystic fibrosis transmembrane conductance regulator dysfunction
  publication-title: World J Otorhinolaryngol Head Neck Surg
– volume: 121
  start-page: 1313
  year: 2011
  end-page: 1319
  article-title: Resveratrol has salutary effects on mucociliary transport and inflammation in sinonasal epithelium
  publication-title: Laryngoscope
– volume: 9
  start-page: 100
  year: 2019
  end-page: 105
  article-title: Resveratrol and ivacaftor are additive G551D CFTR‐channel potentiators: therapeutic implications for cystic fibrosis sinus disease
  publication-title: Int Forum Allergy Rhinol
– volume: 120
  start-page: 1051
  year: 2010
  end-page: 1056
  article-title: The bioflavonoid compound, sinupret, stimulates transepithelial chloride transport in vitro and in vivo
  publication-title: Laryngoscope
– volume: 8
  year: 2013
  article-title: Resveratrol enhances airway surface liquid depth in sinonasal epithelium by increasing cystic fibrosis transmembrane conductance regulator open probability
  publication-title: PLoS One
– volume: 11
  year: 2015
  article-title: Virulence factors of induce both the unfolded protein and integrated stress responses in airway epithelial cells
  publication-title: PLoS Pathog
– ident: e_1_2_5_9_1
  doi: 10.1016/j.wjorl.2018.09.001
– ident: e_1_2_5_14_1
  doi: 10.1002/lary.25335
– ident: e_1_2_5_42_1
  doi: 10.1016/j.otohns.2010.05.021
– ident: e_1_2_5_12_1
  doi: 10.3389/fcimb.2017.00540
– ident: e_1_2_5_20_1
  doi: 10.1073/pnas.0904709106
– ident: e_1_2_5_36_1
  doi: 10.2500/ajra.2010.24.3379
– ident: e_1_2_5_24_1
  doi: 10.1002/alr.22514
– ident: e_1_2_5_29_1
  doi: 10.1002/alr.22251
– ident: e_1_2_5_38_1
  doi: 10.2500/ajr.2007.21.3068
– ident: e_1_2_5_25_1
  doi: 10.1002/alr.22202
– ident: e_1_2_5_44_1
  doi: 10.1002/alr.21335
– ident: e_1_2_5_48_1
  doi: 10.1371/journal.ppat.1004946
– volume: 79
  start-page: 78
  year: 2016
  ident: e_1_2_5_10_1
  article-title: Acquired cystic fibrosis transmembrane conductance regulator deficiency
  publication-title: Adv Otorhinolaryngol
  contributor:
    fullname: Cho DY
– ident: e_1_2_5_31_1
  doi: 10.3389/fcimb.2020.00412
– ident: e_1_2_5_46_1
  doi: 10.1126/scitranslmed.aav3505
– ident: e_1_2_5_32_1
  doi: 10.1002/alr.22290
– ident: e_1_2_5_23_1
  doi: 10.1002/lio2.423
– volume: 139
  start-page: 822
  year: 2013
  ident: e_1_2_5_40_1
  article-title: Comparison of cystic fibrosis transmembrane conductance regulator (CFTR) and ciliary beat frequency activation by the CFTR modulators genistein, VRT‐532, and UCCF‐152 in primary sinonasal epithelial cultures
  publication-title: JAMA Otolaryngol
  contributor:
    fullname: Conger BT
– ident: e_1_2_5_27_1
  doi: 10.1177/1945892418815615
– ident: e_1_2_5_30_1
  doi: 10.1164/rccm.202002-0369OC
– ident: e_1_2_5_39_1
  doi: 10.1371/journal.pone.0081589
– ident: e_1_2_5_21_1
  doi: 10.1038/nrdp.2015.10
– ident: e_1_2_5_13_1
  doi: 10.1016/j.redox.2021.101998
– ident: e_1_2_5_2_1
  doi: 10.1016/j.ijporl.2019.05.034
– ident: e_1_2_5_34_1
  doi: 10.1002/alr.21892
– ident: e_1_2_5_41_1
  doi: 10.2500/ajra.2011.25.3643
– ident: e_1_2_5_28_1
  doi: 10.1002/alr.22088
– ident: e_1_2_5_37_1
  doi: 10.2500/ajr.2008.22.3125
– ident: e_1_2_5_33_1
  doi: 10.1002/alr.22081
– ident: e_1_2_5_47_1
  doi: 10.1371/journal.pone.0054473
– ident: e_1_2_5_7_1
  doi: 10.1097/MCP.0000000000000107
– ident: e_1_2_5_4_1
  doi: 10.1007/s40136-017-0139-3
– ident: e_1_2_5_11_1
  doi: 10.1165/rcmb.2010-0133OC
– ident: e_1_2_5_22_1
  doi: 10.1056/NEJMoa0909825
– ident: e_1_2_5_26_1
  doi: 10.1002/alr.22285
– ident: e_1_2_5_17_1
  doi: 10.1002/lary.23278
– ident: e_1_2_5_16_1
  doi: 10.1002/lary.20930
– volume: 10
  year: 2019
  ident: e_1_2_5_3_1
  article-title: Medical interventions for chronic rhinosinusitis in cystic fibrosis
  publication-title: Cochrane Database Syst Rev
  contributor:
    fullname: Karanth TK
– ident: e_1_2_5_18_1
  doi: 10.1096/fj.14-268755
– ident: e_1_2_5_19_1
  doi: 10.1002/alr.21975
– ident: e_1_2_5_8_1
  doi: 10.1002/alr.22065
– ident: e_1_2_5_15_1
  doi: 10.1002/lary.21921
– ident: e_1_2_5_43_1
  doi: 10.2500/ajra.2009.23.3285
– ident: e_1_2_5_5_1
  doi: 10.1371/journal.pone.0072398
– ident: e_1_2_5_45_1
  doi: 10.1002/lary.20871
– ident: e_1_2_5_6_1
  doi: 10.1007/s11882-020-00916-6
– ident: e_1_2_5_35_1
  doi: 10.1002/lary.21798
SSID ssj0000515517
Score 2.3487825
Snippet Background Abnormal chloride (Cl–) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis....
Abnormal chloride (Cl ) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis. As an...
Background Abnormal chloride (Cl – ) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic...
BackgroundAbnormal chloride (Cl–) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis....
BACKGROUNDAbnormal chloride (Cl- ) transport dehydrates airway surface liquid (ASL) in sinonasal epithelium leading to mucus stasis and chronic rhinosinusitis....
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 690
SubjectTerms Aminophenols
Animals
CFTR
Chloride transport
Chlorides - metabolism
chronic rhinosinusitis
chronic sinusitis
Cystic fibrosis
Cystic Fibrosis Transmembrane Conductance Regulator
Epithelium
Forskolin
Humans
ivacaftor
micro‐optical coherence tomography
Mucociliary Clearance
mucociliary transport
Mucus
Nasal Mucosa - metabolism
Pseudomonas aeruginosa
Quinolones
Rabbits
Respiratory tract
Rhinitis
Rhinosinusitis
Sinus
Sinusitis
Sinusitis - drug therapy
Therapeutic applications
Title Ivacaftor restores delayed mucociliary transport caused by Pseudomonas aeruginosa–induced acquired cystic fibrosis transmembrane conductance regulator dysfunction in rabbit nasal epithelia
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Falr.22907
https://www.ncbi.nlm.nih.gov/pubmed/34704673
https://www.proquest.com/docview/2654501903/abstract/
https://search.proquest.com/docview/2587000624
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9NAFB5qF8QX8b7VVUbxQShZc500j91LWZfuKtJCfQozk8k20CZL0gj1t_nmH_PMTG6lCqsvJaRtJvR8PZfJd76D0HvIIGIiImpY1GSGa5mxQZ2Ra7i2EL5JOGO-7Ea-uiYXc_dy4S16vV8d1lK5Ycf8xx_7Sv7HqnAO7Cq7ZP_Bss1F4QQcg33hFSwMr3ey8afvlNMYquZhrgbEiGIoRR-3kESuS_B0ySqRpLhNLWA-5LQsdMr5pRBllMGd0mJIRV7eJGlWUAMq9FIyAiiXDGE44Fsp5DyMoarOpHaJutZarKHIThXRXerFqraDXE-1h5uJtoUMlzWNMqeMJZshrARwELeyCWSV0G5WvLstqfQhFD9BtineaEpPvkx2nwCcLjNdABjfREslaPe_lzTbtsjvzBjTTfUto3mq50mfyaFLl5UOebUNAhV0Qzo8Fspd2rLRiAR64Fzj2-0Ohr2OoyZ6SGkV84mehL0XTrQ8LV3lx1IW329jZs0TuP4cTubTaTg7X8zuoQPbDzy_jw7GJ2cnk2arT4_R8WtdK9P-2FxxNxvaK3F2KyaV8sweoYdVrYLHGniPUU-kT9D9q4qN8RT9bPCHa_zhCn-4gz_c4A9r_GG2xR384X384Rp_WOMP1_jDO_jDHfzhBn-4gz-cpFjjDyv84QZ_z9B8cj47vTCqaSAGd2QkFIRxO_KEF0eEQ1VsW4wRShhxyIiNwLMEnrAcykc0ZkEQxVD6x3YEroa63LMj6jxH_TRLxSHCrhmYTPiQ3AvhUotSJxYQaJkpGBlZDh-gd7VVwlst-hJqeW87BNOFynQDdFTbK6x8QhHaBCoSKc_gDNDb5m3w2PIxHPwuWQmf8SBGyt5ld4BeaDs3qziub0LqAt_-oAz_9-XD8fSrOnh5h4VeoQftf-YI9Td5KV5DMr1hbyqw_gav-t2J
link.rule.ids 315,786,790,27957,27958
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ivacaftor+restores+delayed+mucociliary+transport+caused+by+Pseudomonas+aeruginosa-induced+acquired+cystic+fibrosis+transmembrane+conductance+regulator+dysfunction+in+rabbit+nasal+epithelia&rft.jtitle=International+forum+of+allergy+%26+rhinology&rft.au=Cho%2C+Do-Yeon&rft.au=Zhang%2C+Shaoyan&rft.au=Skinner%2C+Daniel+F&rft.au=Lim%2C+Dong+Jin&rft.date=2022-05-01&rft.eissn=2042-6984&rft.volume=12&rft.issue=5&rft.spage=690&rft.epage=698&rft_id=info:doi/10.1002%2Falr.22907&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2042-6976&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2042-6976&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2042-6976&client=summon